What question did this study set out to answer?

This research investigates the electrophysiological effects of MS-551 and compares its potency to (+)-sotalol in rabbit ventricular myocytes.

May 1, 1993British Journal of PharmacologyOpen Access

Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

View Full Paper

Ask AI

Bookmark

Why the study?

Does MS-551 affect action potential and membrane currents differently than (+)-sotalol in rabbit ventricular myocytes?

Population

Rabbit ventricular myocytes and isolated ventricular muscles

Comparison

MS-551 (0.1-10 microM) vs (+)-sotalol (3-100 microM)

Design

Preclinical

Authors

HNHaruaki NakayaElectrophysiology NTNoritsugu TohseSapporo Medical University YTYouji TakedaHokkaido University

Discussion

Member takes

Implication

Should not yet change arrhythmia management; extends preclinical evidence for multi-channel potassium blockade beyond sotalol.

Key Points

This research investigates the electrophysiological effects of MS-551 and compares its potency to (+)-sotalol in rabbit ventricular myocytes.
Electrophysiological assessment of action potential and membrane currents in rabbit ventricular cells.
Comparison of MS-551 (0.1-10 µM) and (+)-sotalol (3-100 µM) effects at a stimulation frequency of 1.0 Hz.
Monitoring of delayed rectifier potassium current (IK) and transient outward current (Ito) in isolated cells.
MS-551 prolonged action potential duration (APD) significantly more than (+)-sotalol with 30 times greater potency.
Both drugs showed reverse use-dependence on APD prolongation, with greater effects at longer cycle lengths.
MS-551 inhibited IK and affected Ito and inward rectifier potassium current (IK1) at higher concentrations, while sotalol did not.

Structured PICO

Does MS-551 affect action potential and membrane currents differently than (+)-sotalol in rabbit ventricular myocytes?

Population

Rabbit ventricular myocytes and isolated ventricular muscles

Intervention

MS-551 (0.1-10 microM)

Comparator

(+)-sotalol (3-100 microM)

Outcome

Electrophysiological effects including action potential duration (APD), effective refractory period, and membrane currents (IK, Ito, IK1)surrogate

MS-551 is a potent, non-specific class III antiarrhythmic drug that inhibits multiple voltage-gated potassium channels in rabbit ventricular cells.

Cite This Study

Nakaya et al. (1993) studied this question.

synapsesocial.com/papers/6a72b173a528af2d65c48113 https://doi.org/10.1111/j.1476-5381.1993.tb13546.x

View Full Paper

Ask AI

Bookmark

Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider